ImmunityBio (IBRX) Income from Non-Controlling Interests (2020 - 2026)
ImmunityBio's Income from Non-Controlling Interests was -$12,000 in Q2 2026, compared with -$19,000 a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, ImmunityBio's Income from Non-Controlling Interests was -$62,000 through Jun 30, 2026; for FY2025, it came in at -$74,000.
- In earlier years, Income from Non-Controlling Interests was -$81,000 in FY2024, -$656,000 in FY2023, -$753,000 in FY2022 and -$3.06 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Income from Non-Controlling Interests in data going back to Q1 2020.
- Per Business Quant data, IBRX's Income from Non-Controlling Interests in the three quarters before Q2 2026 was -$15,000 (Q1 2026), -$14,000 (Q4 2025) and -$21,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn | -12,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Sep 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -334,000.00 |
| Mar 31, 2023 | -240,000.00 |
| Dec 31, 2022 | -111,000.00 |
| Sep 30, 2022 | -223,000.00 |
| Jun 30, 2022 | -247,000.00 |
| Mar 31, 2022 | -172,000.00 |
| Dec 31, 2021 | -294,000.00 |
| Sep 30, 2021 | -800,000.00 |
API Access
ImmunityBio Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();